FIELD: medicine.
SUBSTANCE: present invention relates to medicinal agents, particularly to liquid dosage compositions for oral administration, meant for treating diseases and conditions caused by cyclooxygenase-2, containing water, 5-methyl-2-(2'-chloro-6'-fluoroaniline)phenylacetic acid and a suspension agent, where pH of the said composition approximately lies between 4.3 and 5.5. The invention also pertains to a method of making the said medicinal agent and minimisation of decomposition of the aqueous suspension.
EFFECT: provision for a liquid dosage composition, stable during storage.
22 cl, 7 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIQUID COMPOSITIONS CONTAINING VALSARTAN | 2008 |
|
RU2488393C2 |
| AQUEOUS SUSPENSIONS OF RILUZOL | 2010 |
|
RU2498802C2 |
| LIQUID COMPOSITIONS CONTAINING MUCOADHESIVE AGENT | 2017 |
|
RU2773140C2 |
| THERMOSTABLE ANTIACID SUSPENSION | 1999 |
|
RU2223092C2 |
| PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2316324C2 |
| AQUEOUS RISPERIDONE COMPOSITIONS | 1995 |
|
RU2161965C2 |
| PER ORAL PHARMACEUTICAL TELBIVUDIN-CONTAINING SOLUTIONS | 2008 |
|
RU2493826C2 |
| PHYSICALLY AND CHEMICALLY STABLE ORAL SUSPENSION OF GIVINOSTAT | 2016 |
|
RU2721396C2 |
| USE OF ORGANIC EXTRACT OF CITRUS FRUITS WITH HIGH ANTIMICROBIAL ACTIVITY AS SYSTEM OF PRESERVING AGENTS IN LIQUIDS, EMULSIONS, SUSPENSIONS, CREAMS AND ANTACIDS | 2016 |
|
RU2714879C2 |
| OXCARBAZEPINE-CONTAINING SUSPENSION | 2000 |
|
RU2277912C2 |
